Animal Parasiticides are used for protecting the animals from infections caused by parasites. Protection of animals from parasitic infections has gained significant importance since the past two decades. The market is segmented on the basis of product type, animal type and geography to a give a comprehensive analysis of the market. The product type includes three segments namely endoparasiticides, ectoparasiticides, and endectocides. These are further sub-segmented based on the formulation type. Animal parasiticides market is driven by factors such as increasing prevalence of parasitic infections, growing investment from government and non-government organizations, the need for improving the yield of animal based food and active implementation of animal welfare acts over the globe. The restraining factors are stringent regulatory approval processes and restriction on use of some parasiticides in few countries, huge investment of time and money for R&D and also emerging instances of resistance to parasitic infections.
The animal parasiticides market is estimated to grow at a CAGR of 5.8% which is currently valued at $6.8 Billion. The innovation in animal parasiticides is leading to the introduction of novel formulation systems in the market.
Sample Companies Profiled in this Report are:
- Bayer AG
- Boehringer Ingelheim
- Bayer AG
- Novartis AG
The overall market has also been presented from the perspective of different geographic locations and key economies in this market. Competitors are highlighted and market players are profiled with attributes covering company overview, financial overview, business strategies, product portfolio and recent developments. Market shares of the each of the prominent players for 2015 are detailed.
The report also provides a detailed qualitative analysis of the factors responsible for driving and hindering the growth of animal parasiticides market and future opportunities that can propel the market.